Globus MedicalMEX:GMED 90 FCF Yield % is 5.52 as of Jul. 04, 2026, which is 129% above its 10-year median of 2.41. GuruFocus rates MEX:GMED with a GF Score™ of 90/100 and a GF Value™ of MXN1,804.37 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Globus Medical ranks better than 84.13% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Globus Medical's FCF Yield % or its related term are showing as below:
MEX:GMED'
s FCF Yield % Range Over the Past 10 Years
Min: 1.28 Med: 2.41 Max: 7.44
Current: 5.52
During the past 13 years, the highest FCF Yield % of Globus Medical was 7.44%. The lowest was 1.28%. And the median was 2.41%.
MEX:GMED's FCF Yield % is ranked better than 84.13% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: -0.4
vs MEX:GMED: 5.52
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Globus Medical FCF Yield % Related Terms
Globus Medical FCF Yield % Historical Data
* Premium members only.
The historical data trend for Globus Medical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GMED vs PEN, PODD, BRKR: FCF Yield % Comparison
For the Medical Devices subindustry, Globus Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Globus Medical's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (MEX:GMED) has a FCF Yield % of 5.52 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Globus Medical and its competitors. This is 129% above median its historical median of 2.41. Over the past decade, Globus Medical's FCF Yield % has ranged from 1.28 to 7.44. According to the industry distribution chart, Globus Medical ranks #136 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is Globus Medical's FCF Yield % too high?
Globus Medical's current FCF Yield % of 5.52 is 129% above median its 10-year median of 2.41. Over the past 10 years, this metric has ranged from a low of 1.28 to a high of 7.44. Based on the distribution chart, Globus Medical ranks #136 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's FCF Yield % compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #136 out of 857 companies for FCF Yield %. This places Globus Medical in the top 16% of its industry — outperforming the majority of peers. Historically, Globus Medical's own FCF Yield % has ranged from 1.28 to 7.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Globus Medical and its competitors. Globus Medical's current FCF Yield % is 5.52, which is 129% above median its own 10-year median of 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,804.37, compared to a current price of MXN1,465.00 — trading 18.8% below its estimated fair value. The current FCF Yield % is 5.52, which is 129% above median its 10-year median of 2.41. Globus Medical's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current FCF Yield % is 5.52 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,465.00 is trading 18.8% below its estimated GF Value™ of MXN1,804.37.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
FCF Yield %: 5.52 (129% above median its 10-year median of 2.41)
GF Value™: MXN1,804.37 vs. price of MXN1,465.00 (18.8% below fair value)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
90GF Score
Get the complete analysis for MEX:GMED
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
